CEDIC-Centro de Investigaciones Clinicas

Caba, Buenos Aires C1425DES

0 studies enrolling now · 4 studies all time

What they study most

Diabetes Mellitus, Type 2, Psoriasis, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk — Completed
• A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes — Completed
• A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) — Completed
• A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes — Completed